Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| OPK | PRESS-RELEASE | neutral | 3/10 | OPKO Health presented preclinical data for OPK8801001, a long-acting hGH receptor antagonist for acromegaly, at ENDO 202 | Jun 15, 2026 |
| PAA | PRESS-RELEASE | bullish | 6/10 | Plains All American Pipeline increased its 2026 growth capital spending guidance from ~$350M to $400-450M, citing improv | Jun 15, 2026 |
| NNDM | PRESS-RELEASE | mixed | 6/10 | Nano Dimension (NNDM) announces a non-binding term sheet to acquire Infinite Epigenetics for $890M, pivoting from 3D pri | Jun 15, 2026 |
| LFCR | PRESS-RELEASE | bullish | 6/10 | Lifecore Biomedical announced a new commercial manufacturing agreement with an unnamed global pharmaceutical company for | Jun 15, 2026 |
| IREN | PRESS-RELEASE | bullish | 7/10 | IREN acquired Nostrum Group, a Spanish developer of grid-connected AI data centers, adding ~490MW of secured power in Sp | Jun 15, 2026 |
| USAR | PRESS-RELEASE | bullish | 5/10 | USA Rare Earth announced commissioning of its hydrometallurgical demonstration facility in Wheat Ridge, Colorado, target | Jun 15, 2026 |
| CODA | PRESS-RELEASE | mixed | 5/10 | Coda Octopus Group reported fiscal Q2 2026 results with EPS of $0.15 beating the $0.13 consensus by 15.4%, but revenue o | Jun 15, 2026 |
| AXSM | PRESS-RELEASE | neutral | 3/10 | Axsome Therapeutics presented new data on AXS-12 and solriamfetol at SLEEP 2026, including cognitive/functional outcomes | Jun 15, 2026 |
| PHVS | PRESS-RELEASE | bullish | 7/10 | Pharvaris presented positive Phase 3 RAPIDe-3 data at EAACI 2026, showing deucrictibant achieved a median time to onset | Jun 15, 2026 |
| CTM | PRESS-RELEASE | bullish | 6/10 | Castellum Inc. announced that its joint venture CTM JV, LLC has been awarded a position on a $250 million maximum-value | Jun 15, 2026 |
| DSX | PRESS-RELEASE | bullish | 7/10 | Diana Shipping (DSX) escalated its activist campaign against Genco Shipping (GNK), urging GNK shareholders to vote again | Jun 15, 2026 |
| PSN | PRESS-RELEASE | bullish | 5/10 | Parsons Corporation announced a $184 million ceiling value single-award IDIQ contract from the Department of the Navy fo | Jun 15, 2026 |
| CNTX | PRESS-RELEASE | bullish | 7/10 | Context Therapeutics reported positive interim Phase 1 data for its CLDN6 x CD3 TCE bispecific antibody, CTIM-76, showin | Jun 15, 2026 |
| GILT | PRESS-RELEASE | bullish | 7/10 | Gilat Satellite Networks announced a transformative $157.5 million cash acquisition of Comtech's Satellite & Space Commu | Jun 15, 2026 |
| FENC | PRESS-RELEASE | neutral | 2/10 | Fennec Pharmaceuticals granted 10,000 incentive stock options to a new non-executive employee at $9.00 per share under i | Jun 15, 2026 |
| OWLS | PRESS-RELEASE | bullish | 5/10 | OwlTing Group announced a cross-border payment partnership with Credible Finance, opening payment corridors starting wit | Jun 15, 2026 |
| SHEL | PRESS-RELEASE | neutral | 2/10 | Shell plc announced the euro and pound sterling equivalent dividend payments for its Q1 2026 interim dividend of US$0.39 | Jun 15, 2026 |
| AAPG | PRESS-RELEASE | mixed | 6/10 | Ascentage Pharma presented 17 clinical updates at EHA2026, including eight posters, for olverembatinib (third-generation | Jun 14, 2026 |
| ZYME | PRESS-RELEASE | bullish | 6/10 | Zymeworks presented Phase 1 dose-escalation data for ZW191, an FRα-targeting ADC, at ESMO Gynaecological Cancers Congres | Jun 14, 2026 |
| CRNX | PRESS-RELEASE | bullish | 6/10 | Crinetics presented positive Phase 2 CAH data at ENDO 2026 showing atumelnant reduced androstenedione by 67% at week 12 | Jun 14, 2026 |
| CRNX | PRESS-RELEASE | bullish | 6/10 | Crinetics presented two-year open-label extension data at ENDO 2026 showing that once-daily oral PALSONIFY (paltusotine) | Jun 14, 2026 |
| CLDX | PRESS-RELEASE | bearish | 6/10 | Celldex reported Q1 2026 EPS of -$1.18, missing consensus of -$1.07 by 10.8%. The press release focuses on positive long | Jun 14, 2026 |
| UPB | PRESS-RELEASE | bullish | 7/10 | Upstream Bio presented positive responder analyses from the Phase 2 VIBRANT trial of verekitug in CRSwNP at EAACI 2026, | Jun 14, 2026 |
| CLDX | PRESS-RELEASE | bullish | 7/10 | Celldex presented positive Phase 1 data for CDX-622, a bispecific antibody targeting SCF and TSLP, at EAACI. The drug sh | Jun 14, 2026 |
| LEGN | PRESS-RELEASE | bullish | 7/10 | Legend Biotech presented first-in-human proof-of-concept data for LB2501, an in vivo CD19/CD20 dual-targeting CAR-T ther | Jun 14, 2026 |
| ASND | PRESS-RELEASE | bullish | 7/10 | Ascendis Pharma announced sustained efficacy and safety data from the Phase 3 PaTHway Trial of TransCon PTH (YORVIPATH) | Jun 13, 2026 |
| AGIO | PRESS-RELEASE | mixed | 7/10 | Agios presented detailed Phase 3 RISE UP data for mitapivat in sickle cell disease at EHA 2026, showing statistically si | Jun 13, 2026 |
| RYTM | PRESS-RELEASE | bullish | 7/10 | Rhythm Pharmaceuticals reported positive Phase 2 data for setmelanotide in Prader-Willi syndrome at ENDO 2026, showing c | Jun 13, 2026 |
| NTLA | PRESS-RELEASE | bullish | 8/10 | Intellia presented additional positive Phase 3 HAELO data for lonvo-z (NTLA-2002) in HAE at EAACI 2026, with the manuscr | Jun 13, 2026 |
| RKDA | PRESS-RELEASE | bearish | 7/10 | Arcadia Biosciences closed a private placement raising approximately $4 million in gross proceeds through the sale of co | Jun 12, 2026 |